EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disclosing the Antifungal Mechanisms of the Cyclam Salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 against Candida albicans and Candida krusei

Inês Costa iD, Inês Lopes, Mariana Morais iD, Renata Silva iD, Fernando Remião iD, Rui Medeiros iD, Luís G Alves iD, Eugénia Pinto iD, Fátima Cerqueira iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25105209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Inês Costa und 8 weiteren Autor:innen. Beteiligte Einrichtung: UCIBIO-Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of …. Hauptthemen laut MEDLINE: Antifungal Agents, Candida albicans, Reactive Oxygen Species, Candida. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, FCT/MCTES—Foundation for Science and Technology, COMPETE—Programa Operacional Factores de Competitividade (POFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycoses are one of the major causes of morbidity/mortality among immunocompromised individuals. Considering the importance of these infections, the World Health Organization (WHO) defined a priority list of fungi for health in 2022 that include Candida albicans as belonging to the critical priority group and Pichia kudriavzevii (Candida krusei) to the medium priority group. The existence of few available antifungal drugs, their high toxicity, the acquired fungal resistance, and the appearance of new species with a broader spectrum of resistance, points out the need for searching for new antifungals, preferably with new and multiple mechanisms of action. The cyclam salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 was previously tested against several fungi and revealed an interesting activity, with minimal inhibitory concentration (MIC) values of 8 µg/mL for C. krusei and of 128 µg/mL for C. albicans. The main objective of the present work was to deeply understand the mechanisms involved in its antifungal activity. The effects of the cyclam salt on yeast metabolic viability (resazurin reduction assay), yeast mitochondrial function (JC-1 probe), production of reactive oxygen species (DCFH-DA probe) and on intracellular ATP levels (luciferin/luciferase assay) were evaluated. H4[H2(4-CF3PhCH2)2Cyclam]Cl4 induced a significant decrease in the metabolic activity of both C. albicans and C. krusei, an increase in Reactive Oxygen Species (ROS) production, and an impaired mitochondrial function. The latter was observed by the depolarization of the mitochondrial membrane and decrease in ATP intracellular levels, mechanisms that seems to be involved in the antifungal activity of H4[H2(4-CF3PhCH2)2Cyclam]Cl4. The interference of the cyclam salt with human cells revealed a CC50 value against HEK-293 embryonic kidney cells of 1.1 μg/mL and a HC10 value against human red blood cells of 0.8 μg/mL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandida albicansReactive Oxygen SpeciesCandidaMicrobial Sensitivity TestsHumansMitochondriaMembrane Potential, MitochondrialPichia

Stichwörter der Autor:innen

cyclam saltmechanism of actionmetabolic viabilitymitochondrial functionyeasts

Substanzen

Antifungal AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • UCIBIO-Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira nº 228, 4050-313 Porto, Portugal.
  • Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
  • Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CC…
  • School of Health, Polytechnic Institute of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal.
  • ICBAS, Abel Salazar Institute for the Biomedical Sciences, University of Porto, Rua Jorge de Viterbo Ferreira 228, 4050-313 Porto, Portugal.
  • FP-I3ID, FP-BHS, GIT-LoSa, University Fernando Pessoa, Praça 9 de Abril 349, 4249-004 Porto, Portugal.

ORCID-Profile: Inês Costa, Mariana Morais, Renata Silva, Fernando Remião, Rui Medeiros, Luís G Alves, Eugénia Pinto, Fátima Cerqueira

Förderung

  • Fundação para a Ciência e Tecnologia
  • FCT/MCTES—Foundation for Science and Technology
  • COMPETE—Programa Operacional Factores de Competitividade (POFC)
  • Group of Marine Natural Products and Medicinal Chemistry CIIMAR
  • Research Center of the Portuguese Oncology Institute of Porto
  • Wellcome Trust (UK) and The University of Queensland (Australia)

Zitieren

APA

Costa, I., Lopes, I., Morais, M., Silva, R., Remião, F., Medeiros, R., Alves, L. G., Pinto, E., & Cerqueira, F. (2024). Disclosing the Antifungal Mechanisms of the Cyclam Salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 against Candida albicans and Candida krusei. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105209

Vancouver

Costa I, Lopes I, Morais M, Silva R, Remião F, Medeiros R, et al. Disclosing the Antifungal Mechanisms of the Cyclam Salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 against Candida albicans and Candida krusei. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105209

BibTeX
@article{Costa2024,
  author = {Costa, Inês and Lopes, Inês and Morais, Mariana and Silva, Renata and Remião, Fernando and Medeiros, Rui and Alves, Luís G and Pinto, Eugénia and Cerqueira, Fátima},
  title = {Disclosing the Antifungal Mechanisms of the Cyclam Salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 against Candida albicans and Candida krusei},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25105209}
}
Kostenlos starten →